| First Author | Hu B | Year | 2011 |
| Journal | Am J Pathol | Volume | 178 |
| Issue | 4 | Pages | 1500-8 |
| PubMed ID | 21435439 | Mgi Jnum | J:169859 |
| Mgi Id | MGI:4943362 | Doi | 10.1016/j.ajpath.2011.01.002 |
| Citation | Hu B, et al. (2011) Essential Role of MeCP2 in the Regulation of Myofibroblast Differentiation during Pulmonary Fibrosis. Am J Pathol 178(4):1500-8 |
| abstractText | DNA methylation is a key mechanism for repression of gene expression, including that of alpha-smooth muscle actin (alpha-SMA) gene expression in fibroblasts. However, the trans-acting factors that interact with the methylated alpha-SMA gene to regulate its expression have not been identified. Using gel shift and chromatin immunoprecipitation (ChIP) assays, methyl CpG binding protein 2 (MeCP2) was shown to bind to the alpha-SMA gene. Suppression of MeCP2 gene expression by siRNA or its deficiency in lung fibroblasts isolated from MeCP2 knockout mice caused significant reduction of alpha-SMA gene expression. In contrast, transient transfection of MeCP2 expression plasmid into fibroblasts enhanced alpha-SMA gene expression. Moreover, in vivo studies revealed that compared to their wild type littermates, MeCP2-deficient mice exhibited significantly decreased alveolar wall thickness, inflammatory cell infiltration, interstitial collagen deposition, and myofibroblast differentiation in response to endotracheal injection of bleomycin. Thus, MeCP2 is essential for myofibroblast differentiation and pulmonary fibrosis. |
